Endpoints News 2025-12-30 Verastem axes Phase 1/2 lung cancer trial of Avmapki, pivots to KRAS blocker
Endpoints News 2025-12-29 Federal judge blocks 340B drug pricing pilot ahead of Jan. 1 effective date
Endpoints News 2025-12-29 ASK Pharm makes China rights deal; Unicycive resubmits kidney drug after CRL
Endpoints News 2025-12-29 As gene editing tools multiply, the hunt for the final technology continues
Endpoints News 2025-12-26 Biohaven’s ion channel drug fails again, this time in major depressive disorder
Endpoints News 2025-12-24 Sanofi to buy hepatitis B vaccine maker Dynavax for $2.2B; gets CRL for MS drug